Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S C Schimpff

Showing results (151-160 of 154) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 154 results.
The American Journal of Medicine|June 7, 1985
Potential of imipenem as single-agent empiric antibiotic therapy of febrile neutropenic patients with cancerJ C Wade, H C Standiford, G L Drusano, et al.
The Journal of Infectious Diseases|March 1, 1990
From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained feverW T Hughes, D Armstrong, G P Bodey, et al.
The American Journal of Medicine|May 30, 1986
A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patientsC A De Jongh, J H Joshi, B W Thompson, et al.
The American Journal of Medicine|July 1, 1982
Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: a comparison between the combination of moxalactam plus amikacin and ticarcillin plus amikacinC A De Jongh, J C Wade, S C Schimpff, et al.
Pageof 16

Showing results (151-160 of 154) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 154 results.
The American Journal of Medicine|June 7, 1985
Potential of imipenem as single-agent empiric antibiotic therapy of febrile neutropenic patients with cancerJ C Wade, H C Standiford, G L Drusano, et al.
The Journal of Infectious Diseases|March 1, 1990
From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained feverW T Hughes, D Armstrong, G P Bodey, et al.
The American Journal of Medicine|May 30, 1986
A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patientsC A De Jongh, J H Joshi, B W Thompson, et al.
The American Journal of Medicine|July 1, 1982
Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: a comparison between the combination of moxalactam plus amikacin and ticarcillin plus amikacinC A De Jongh, J C Wade, S C Schimpff, et al.
Pageof 16